# EDGAR Filing Document

**Accession Number:** 0000102816
**File Stem:** 0001410368-26-040148
**Filing Date:** 2026-4
**Character Count:** 20531
**Document Hash:** 141257e212b70244e1ae562d88f90ce4
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001410368-26-040148.hdr.sgml**: 20260424

**ACCESSION NUMBER**: 0001410368-26-040148

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260228

**FILED AS OF DATE**: 20260424

**DATE AS OF CHANGE**: 20260424

**PERIOD START**: 20260831

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Eaton Vance Growth Trust
- **CENTRAL INDEX KEY:** 0000102816

**ORGANIZATION NAME:**
- **EIN:** 042325690

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-01241
- **FILM NUMBER:** 26892220

**BUSINESS ADDRESS:**
- **STREET 1:** ONE POST OFFICE SQUARE
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109
- **BUSINESS PHONE:** 617-482-8260

**MAIL ADDRESS:**
- **STREET 1:** ONE POST OFFICE SQUARE
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02109

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EATON VANCE GROWTH TRUST
- **DATE OF NAME CHANGE:** 19930616

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** EATON VANCE GROWTH FUND INC
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** VANCE SANDERS COMMON STOCK FUND INC
- **DATE OF NAME CHANGE:** 19820915

## Series and Classes Contracts Data

### Eaton Vance Worldwide Health Sciences Fund (Series ID: S000005202)

| Class ID   | Class Name                                         | Ticker Symbol   |
|:---|:---|:---|
| C000014191 | Eaton Vance Worldwide Health Sciences Fund Class A | ETHSX           |
| C000014193 | Eaton Vance Worldwide Health Sciences Fund Class C | ECHSX           |
| C000014194 | Eaton Vance Worldwide Health Sciences Fund Class R | ERHSX           |
| C000081646 | Eaton Vance Worldwide Health Sciences Fund Class I | EIHSX           |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Eaton Vance Growth Trust

- **b. Investment Company Act file number:** 811-01241

- **c. CIK number of Registrant:** 0000102816

- **d. LEI of Registrant:** 549300IUJG72RXOVY252

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** One Post Office Square

  - **City:** Boston

  - **State:** MA

  - **Foreign country:** US

  - **Zip / Postal Code:** 02109

  - **Telephone number:** 617-482-8260

**Item A.2. Information about the Series.**

- **a. Name of Series:** Eaton Vance Worldwide Health Sciences Fund

- **b. EDGAR series identifier (if any):** S000005202

- **c. LEI of Series:** 549300CI26YJYCASE766

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-08-31

- **b. Date as of which information is reported:** 2026-02-28

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $859606705.25

**Total Liabilities:** $1573162.61

**Net Assets:** $858033542.64

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000081646 | -0.36%               | 0.36%                | 1.52%                |
| Class ID C000014193 | -0.52%               | 0.30%                | 1.43%                |
| Class ID C000014191 | -0.41%               | 0.30%                | 1.50%                |
| Class ID C000014194 | -0.45%               | 0.34%                | 1.50%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $5136986.63              | $-8924494.49                               |
| Month 2  | $7570519.47              | $-4664375.21                               |
| Month 3  | $11988336.59             | $1512218.46                                |

### Schedule of Portfolio Investments

| Name                                           | Title                                                               | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Amplifon SpA                                   | Amplifon SpA                                                        | CUSIP: 000000000<br>LEI: ZYXJDNVM2JI3VBM8G556 | Long             | EC               | CORP              | IT        |    225283 | NS      | $3494205.31   | 0.41%             |  |  |  | No            |                  2 | On Loan: No      |
| Newamsterdam Pharma Co NV                      | Newamsterdam Pharma Co NV                                           | CUSIP: 000000000<br>LEI: 984500B6549TF6E14D36 | Long             | EC               | CORP              | NL        |     81652 | NS      | $2895379.92   | 0.34%             |  |  |  | No            |                  1 | On Loan: No      |
| Vertex Pharmaceuticals Inc                     | Vertex Pharmaceuticals Inc                                          | CUSIP: 92532F100<br>LEI: 54930015RAQRRZ5ZGJ91 | Long             | EC               | CORP              | US        |     60680 | NS      | $30147644.40  | 3.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson                              | Johnson & Johnson                                                   | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |    216808 | NS      | $53861611.44  | 6.28%             |  |  |  | No            |                  1 | On Loan: No      |
| UnitedHealth Group Inc                         | UnitedHealth Group Inc                                              | CUSIP: 91324P102<br>LEI: 549300GHBMY8T5GXDE41 | Long             | EC               | CORP              | US        |    109349 | NS      | $32068781.23  | 3.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Straumann Holding AG                           | Straumann Holding AG                                                | CUSIP: 000000000<br>LEI: 50670046ML5FVIM60Z37 | Long             | EC               | CORP              | CH        |     83976 | NS      | $10054081.29  | 1.17%             |  |  |  | No            |                  2 | On Loan: No      |
| AbbVie Inc                                     | AbbVie Inc                                                          | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |    246272 | NS      | $57154805.76  | 6.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Thermo Fisher Scientific Inc                   | Thermo Fisher Scientific Inc                                        | CUSIP: 883556102<br>LEI: HCHV7422L5HDJZCRFL38 | Long             | EC               | CORP              | US        |     47190 | NS      | $24591180.90  | 2.87%             |  |  |  | No            |                  1 | On Loan: No      |
| Cooper Cos Inc/The                             | Cooper Cos Inc/The                                                  | CUSIP: 216648501<br>LEI: QJKMVPIGLH7530PCUE20 | Long             | EC               | CORP              | US        |    128221 | NS      | $10728251.07  | 1.25%             |  |  |  | No            |                  1 | On Loan: No      |
| HeartFlow Inc                                  | HeartFlow Inc                                                       | CUSIP: 42238D107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    218978 | NS      | $5071530.48   | 0.59%             |  |  |  | No            |                  1 | On Loan: No      |
| Medtronic PLC                                  | Medtronic PLC                                                       | CUSIP: 000000000<br>LEI: 549300GX3ZBSQWUXY261 | Long             | EC               | CORP              | IE        |    185134 | NS      | $18080186.44  | 2.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Genmab A/S                                     | Genmab A/S                                                          | CUSIP: 000000000<br>LEI: 529900MTJPDPE4MHJ122 | Long             | EC               | CORP              | DK        |     16690 | NS      | $4913977.40   | 0.57%             |  |  |  | No            |                  2 | On Loan: No      |
| Roche Holding AG                               | Roche Holding AG                                                    | CUSIP: 000000000<br>LEI: 549300U41AUUVOAAOB37 | Long             | EC               | CORP              | CH        |    105518 | NS      | $50216164.83  | 5.85%             |  |  |  | No            |                  2 | On Loan: No      |
| Zoetis Inc                                     | Zoetis Inc                                                          | CUSIP: 98978V103<br>LEI: 549300HD9Q1LOC9KLJ48 | Long             | EC               | CORP              | US        |    200609 | NS      | $26299839.90  | 3.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Boston Scientific Corp                         | Boston Scientific Corp                                              | CUSIP: 101137107<br>LEI: Y6ZDD9FP4P8JSSJMW954 | Long             | EC               | CORP              | US        |    294341 | NS      | $22620105.85  | 2.64%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                               | Novo Nordisk A/S                                                    | CUSIP: 000000000<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |    283516 | NS      | $10723574.98  | 1.25%             |  |  |  | No            |                  2 | On Loan: No      |
| Stryker Corp                                   | Stryker Corp                                                        | CUSIP: 863667101<br>LEI: 5493002F0SC4JTBU5137 | Long             | EC               | CORP              | US        |     54948 | NS      | $21290152.08  | 2.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Centessa Pharmaceuticals PLC                   | Centessa Pharmaceuticals PLC                                        | CUSIP: 152309100<br>LEI: 213800GIDAARDSKOI827 | Long             | EC               | CORP              | GB        |     91966 | NS      | $2470206.76   | 0.29%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                                | AstraZeneca PLC                                                     | CUSIP: 000000000<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |    266858 | NS      | $56155661.59  | 6.54%             |  |  |  | No            |                  2 | On Loan: No      |
| Intuitive Surgical Inc                         | Intuitive Surgical Inc                                              | CUSIP: 46120E602<br>LEI: 54930052SRG011710797 | Long             | EC               | CORP              | US        |     48480 | NS      | $24410164.80  | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Caris Life Sciences Inc                        | Caris Life Sciences Inc                                             | CUSIP: 142152107<br>LEI: 549300LX5LO78M5VPY43 | Long             | EC               | CORP              | US        |    135807 | NS      | $2735152.98   | 0.32%             |  |  |  | No            |                  1 | On Loan: No      |
| Abbott Laboratories                            | Abbott Laboratories                                                 | CUSIP: 002824100<br>LEI: HQD377W2YR662HK5JX27 | Long             | EC               | CORP              | US        |    236553 | NS      | $27522941.55  | 3.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Lonza Group AG                                 | Lonza Group AG                                                      | CUSIP: 000000000<br>LEI: 549300EFW4H2TCZ71055 | Long             | EC               | CORP              | CH        |     21984 | NS      | $15290805.11  | 1.78%             |  |  |  | No            |                  2 | On Loan: No      |
| Xenon Pharmaceuticals Inc                      | Xenon Pharmaceuticals Inc                                           | CUSIP: 98420N105<br>LEI: 549300XV44Q9Z1MIPQ03 | Long             | EC               | CORP              | CA        |     51377 | NS      | $2221027.71   | 0.26%             |  |  |  | No            |                  1 | On Loan: No      |
| CSL Ltd                                        | CSL Ltd                                                             | CUSIP: 000000000<br>LEI: 529900ECSECK5ZDQTE14 | Long             | EC               | CORP              | AU        |    134162 | NS      | $14044960.29  | 1.64%             |  |  |  | No            |                  2 | On Loan: No      |
| Bio-Techne Corp                                | Bio-Techne Corp                                                     | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |    100598 | NS      | $5935282.00   | 0.69%             |  |  |  | No            |                  1 | On Loan: No      |
| Edwards Lifesciences Corp                      | Edwards Lifesciences Corp                                           | CUSIP: 28176E108<br>LEI: YA13X31F3V31L8TMPR58 | Long             | EC               | CORP              | US        |    146286 | NS      | $12649350.42  | 1.47%             |  |  |  | No            |                  1 | On Loan: No      |
| Apogee Therapeutics Inc                        | Apogee Therapeutics Inc                                             | CUSIP: 03770N101<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     33655 | NS      | $2355850.00   | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Argenx SE                                      | Argenx SE                                                           | CUSIP: 04016X101<br>LEI: 7245009C5FZE6G9ODQ71 | Long             | EC               | CORP              | NL        |     17543 | NS      | $13454077.56  | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Morgan Stanley & Co. LLC                       | Morgan Stanley Institutional Liquidity Funds - Government Portfolio | CUSIP: 61747C707<br>LEI: 549300BI6Y5SI6BYPB26 | Long             | STIV             | RF                | US        |    242780 | NS      | $242779.78    | 0.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Option Care Health Inc                         | Option Care Health Inc                                              | CUSIP: 68404L201<br>LEI: 549300DI3Q5ACSYJRI17 | Long             | EC               | CORP              | US        |    178995 | NS      | $5810177.70   | 0.68%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi SA                                      | Sanofi SA                                                           | CUSIP: 000000000<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |    254833 | NS      | $24922999.53  | 2.90%             |  |  |  | No            |                  2 | On Loan: No      |
| Neurocrine Biosciences Inc                     | Neurocrine Biosciences Inc                                          | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |     51654 | NS      | $6831241.50   | 0.80%             |  |  |  | No            |                  1 | On Loan: No      |
| EssilorLuxottica SA                            | EssilorLuxottica SA                                                 | CUSIP: 000000000<br>LEI: 549300M3VH1A3ER1TB49 | Long             | EC               | CORP              | FR        |     10648 | NS      | $2818385.41   | 0.33%             |  |  |  | No            |                  2 | On Loan: No      |
| McKesson Corp                                  | McKesson Corp                                                       | CUSIP: 58155Q103<br>LEI: 549300WZWOM80UCFSF54 | Long             | EC               | CORP              | US        |      6322 | NS      | $6242153.14   | 0.73%             |  |  |  | No            |                  1 | On Loan: No      |
| Danaher Corp                                   | Danaher Corp                                                        | CUSIP: 235851102<br>LEI: S4BKK9OTCEWQ3YHPFM11 | Long             | EC               | CORP              | US        |     37052 | NS      | $7804633.28   | 0.91%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                                    | Novartis AG                                                         | CUSIP: 000000000<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |     70029 | NS      | $11774798.11  | 1.37%             |  |  |  | No            |                  2 | On Loan: No      |
| Mettler-Toledo International Inc               | Mettler-Toledo International Inc                                    | CUSIP: 592688105<br>LEI: 5493000BD5GJNUDIUG10 | Long             | EC               | CORP              | US        |      8731 | NS      | $11932570.39  | 1.39%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                                 | Merck & Co Inc                                                      | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |    307185 | NS      | $38035646.70  | 4.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                                 | Eli Lilly & Co                                                      | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |     92406 | NS      | $97210187.94  | 11.33%            |  |  |  | No            |                  1 | On Loan: No      |
| Recordati Industria Chimica e Farmaceutica SpA | Recordati Industria Chimica e Farmaceutica SpA                      | CUSIP: 000000000<br>LEI: 815600FBF92FD3531704 | Long             | EC               | CORP              | IT        |     91672 | NS      | $5237578.35   | 0.61%             |  |  |  | No            |                  2 | On Loan: No      |
| Royalty Pharma PLC                             | Royalty Pharma PLC                                                  | CUSIP: 000000000<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    215358 | NS      | $9951693.18   | 1.16%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co                        | Bristol-Myers Squibb Co                                             | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |    563654 | NS      | $35155099.98  | 4.10%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc                            | Gilead Sciences Inc                                                 | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    188375 | NS      | $28058456.25  | 3.27%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-03-25

**Name of Applicant:** Eaton Vance Growth Trust

**Signature:** James Kirchner

**Name of Signer:** James Kirchner

**Title:** Treasurer